Total Liabilities Summary of Shanghai Pharmaceuticals Holding Co., Ltd

Shanghai Pharmaceuticals Holding Co., Ltd's latest annual total liabilities in 2023 was 131.08 Billion CNY , up 9.11% from previous year.
Shanghai Pharmaceuticals Holding Co., Ltd's latest quarterly total liabilities in 2024 Q2 was 138.54 Billion CNY , up 2.38% from previous quarter.
Shanghai Pharmaceuticals Holding Co., Ltd reported annual total liabilities of 120.13 Billion CNY in 2022, up 15.1% from previous year.
Shanghai Pharmaceuticals Holding Co., Ltd reported annual total liabilities of 104.36 Billion CNY in 2021, up 10.51% from previous year.
Shanghai Pharmaceuticals Holding Co., Ltd reported quarterly total liabilities of 140.58 Billion CNY for 2024 Q3, up 1.47% from previous quarter.
Shanghai Pharmaceuticals Holding Co., Ltd reported quarterly total liabilities of 135.33 Billion CNY for 2024 Q1, up 3.24% from previous quarter.

Annual Total Liabilities Chart of Shanghai Pharmaceuticals Holding Co., Ltd (2023 - 1994)

Historical Annual Total Liabilities of Shanghai Pharmaceuticals Holding Co., Ltd (2023 - 1994)

Year	Total Liabilities	Total Liabilities Growth
2023	131.08 Billion CNY	9.11%
2022	120.13 Billion CNY	15.1%
2021	104.36 Billion CNY	10.51%
2020	94.44 Billion CNY	7.76%
2019	87.64 Billion CNY	8.94%
2018	80.44 Billion CNY	47.15%
2017	54.66 Billion CNY	19.08%
2016	45.9 Billion CNY	13.25%
2015	40.53 Billion CNY	21.94%
2014	33.24 Billion CNY	21.72%
2013	27.31 Billion CNY	16.87%
2012	23.36 Billion CNY	7.76%
2011	21.68 Billion CNY	33.17%
2010	16.28 Billion CNY	157.08%
2009	6.33 Billion CNY	11.8%
2008	5.66 Billion CNY	9.65%
2007	5.16 Billion CNY	12.05%
2006	4.61 Billion CNY	5.53%
2005	4.37 Billion CNY	-0.75%
2004	4.4 Billion CNY	9.33%
2003	4.02 Billion CNY	18.34%
2002	3.4 Billion CNY	37.51%
2001	2.47 Billion CNY	-2.94%
2000	2.54 Billion CNY	15.61%
1999	2.2 Billion CNY	16.23%
1998	1.89 Billion CNY	518.28%
1997	306.94 Million CNY	-1.92%
1996	312.95 Million CNY	17.26%
1995	266.87 Million CNY	18.53%
1994	225.15 Million CNY	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	138.54 Billion CNY	2.38%
2024 Q3	140.58 Billion CNY	1.47%
2024 Q1	135.33 Billion CNY	3.24%
2023 Q1	126.15 Billion CNY	5.01%
2023 Q2	134.37 Billion CNY	6.52%
2023 Q3	133 Billion CNY	-1.02%
2023 FY	131.08 Billion CNY	9.11%
2023 Q4	131.08 Billion CNY	-1.45%
2022 Q1	107.64 Billion CNY	3.14%
2022 Q3	118 Billion CNY	5.9%
2022 Q2	111.43 Billion CNY	3.52%
2022 Q4	120.13 Billion CNY	1.81%
2022 FY	120.13 Billion CNY	15.1%
2021 FY	104.36 Billion CNY	10.51%
2021 Q1	99.29 Billion CNY	5.14%
2021 Q2	101.13 Billion CNY	1.85%
2021 Q3	105.17 Billion CNY	4.0%
2021 Q4	104.36 Billion CNY	-0.77%
2020 Q2	96.13 Billion CNY	6.95%
2020 Q1	89.89 Billion CNY	2.57%
2020 Q3	95.44 Billion CNY	-0.72%
2020 FY	94.44 Billion CNY	7.76%
2020 Q4	94.44 Billion CNY	-1.05%
2019 Q2	86.07 Billion CNY	-0.47%
2019 Q1	86.48 Billion CNY	7.5%
2019 FY	87.64 Billion CNY	8.94%
2019 Q4	87.64 Billion CNY	0.88%
2019 Q3	86.87 Billion CNY	0.93%
2018 Q4	80.44 Billion CNY	2.12%
2018 Q2	74.93 Billion CNY	6.73%
2018 Q3	78.77 Billion CNY	5.13%
2018 FY	80.44 Billion CNY	47.15%
2018 Q1	70.2 Billion CNY	28.42%
2017 FY	54.66 Billion CNY	19.08%
2017 Q4	54.66 Billion CNY	3.01%
2017 Q3	53.06 Billion CNY	0.72%
2017 Q2	52.68 Billion CNY	3.42%
2017 Q1	50.94 Billion CNY	10.97%
2016 Q4	45.9 Billion CNY	2.02%
2016 Q1	42.75 Billion CNY	5.49%
2016 FY	45.9 Billion CNY	13.25%
2016 Q3	44.99 Billion CNY	2.37%
2016 Q2	43.95 Billion CNY	2.8%
2015 Q3	39.77 Billion CNY	4.9%
2015 Q1	35.35 Billion CNY	6.35%
2015 FY	40.53 Billion CNY	21.94%
2015 Q4	40.53 Billion CNY	1.91%
2015 Q2	37.91 Billion CNY	7.26%
2014 Q3	34.34 Billion CNY	2.94%
2014 Q1	28.67 Billion CNY	5.0%
2014 Q4	33.24 Billion CNY	-3.21%
2014 Q2	33.36 Billion CNY	16.35%
2014 FY	33.24 Billion CNY	21.72%
2013 Q4	27.31 Billion CNY	2.93%
2013 FY	27.31 Billion CNY	16.87%
2013 Q1	24.5 Billion CNY	4.88%
2013 Q3	26.53 Billion CNY	1.02%
2013 Q2	26.26 Billion CNY	7.17%
2012 Q2	23.8 Billion CNY	5.01%
2012 Q4	23.36 Billion CNY	-1.72%
2012 Q3	23.77 Billion CNY	-0.13%
2012 FY	23.36 Billion CNY	7.76%
2012 Q1	22.67 Billion CNY	4.54%
2011 FY	21.68 Billion CNY	33.17%
2011 Q1	19.03 Billion CNY	16.89%
2011 Q2	19.96 Billion CNY	4.9%
2011 Q3	22.7 Billion CNY	13.72%
2011 Q4	21.68 Billion CNY	-4.5%
2010 Q1	13.18 Billion CNY	108.19%
2010 FY	16.28 Billion CNY	157.08%
2010 Q4	16.28 Billion CNY	10.56%
2010 Q3	14.72 Billion CNY	9.61%
2010 Q2	13.43 Billion CNY	1.89%
2009 Q1	6.37 Billion CNY	12.49%
2009 Q2	6.42 Billion CNY	0.86%
2009 Q4	6.33 Billion CNY	-8.33%
2009 Q3	6.91 Billion CNY	7.5%
2009 FY	6.33 Billion CNY	11.8%
2008 Q2	5.99 Billion CNY	0.72%
2008 FY	5.66 Billion CNY	9.65%
2008 Q3	6.1 Billion CNY	1.81%
2008 Q4	5.66 Billion CNY	-7.25%
2008 Q1	5.95 Billion CNY	15.28%
2007 FY	5.16 Billion CNY	12.05%
2007 Q1	4.9 Billion CNY	6.34%
2007 Q2	5.05 Billion CNY	3.16%
2007 Q3	5.35 Billion CNY	5.88%
2007 Q4	5.16 Billion CNY	-3.53%
2006 FY	4.61 Billion CNY	5.53%
2006 Q4	4.61 Billion CNY	-1.57%
2006 Q1	4.86 Billion CNY	11.36%
2006 Q2	4.72 Billion CNY	-2.9%
2006 Q3	4.68 Billion CNY	-0.86%
2005 Q1	5.26 Billion CNY	19.53%
2005 Q3	5.13 Billion CNY	0.56%
2005 Q4	4.37 Billion CNY	-14.9%
2005 FY	4.37 Billion CNY	-0.75%
2005 Q2	5.1 Billion CNY	-2.98%
2004 Q3	5.03 Billion CNY	14.58%
2004 Q4	4.4 Billion CNY	-12.61%
2004 Q2	4.39 Billion CNY	-3.29%
2004 Q1	4.54 Billion CNY	12.9%
2004 FY	4.4 Billion CNY	9.33%
2003 Q3	3.94 Billion CNY	3.87%
2003 Q4	4.02 Billion CNY	2.0%
2003 FY	4.02 Billion CNY	18.34%
2003 Q1	3.76 Billion CNY	10.73%
2003 Q2	3.8 Billion CNY	0.87%
2002 Q4	3.4 Billion CNY	-1.63%
2002 FY	3.4 Billion CNY	37.51%
2002 Q1	2.97 Billion CNY	20.24%
2002 Q2	3.33 Billion CNY	12.13%
2002 Q3	3.45 Billion CNY	3.68%
2001 Q2	1.95 Billion CNY	0.0%
2001 Q4	2.47 Billion CNY	0.0%
2001 FY	2.47 Billion CNY	-2.94%
2000 FY	2.54 Billion CNY	15.61%
2000 Q4	2.54 Billion CNY	0.0%
2000 Q2	2.59 Billion CNY	0.0%
1999 FY	2.2 Billion CNY	16.23%
1999 Q4	2.2 Billion CNY	0.0%
1999 Q2	1.91 Billion CNY	0.0%
1998 FY	1.89 Billion CNY	518.28%
1997 Q4	306.94 Million CNY	0.0%
1997 Q2	252.52 Million CNY	0.0%
1997 FY	306.94 Million CNY	-1.92%
1996 FY	312.95 Million CNY	17.26%
1996 Q4	312.95 Million CNY	0.0%
1996 Q2	281 Million CNY	0.0%
1995 Q4	266.87 Million CNY	0.0%
1995 Q2	230.88 Million CNY	0.0%
1995 FY	266.87 Million CNY	18.53%
1994 FY	225.15 Million CNY	0.0%
1994 Q2	190.96 Million CNY	0.0%
1994 Q4	225.15 Million CNY	0.0%

Peer Total Liabilities Comparison of Shanghai Pharmaceuticals Holding Co., Ltd

Name	Total Liabilities	Total Liabilities Difference
China Meheco Group Co., Ltd.	21.47 Billion CNY	-510.426%
Liaoning Cheng Da Co., Ltd.	15.16 Billion CNY	-764.402%
Guangxi LiuYao Group Co., Ltd	13.09 Billion CNY	-900.941%

Global Stocks Search

Shanghai Pharmaceuticals Holding Co., Ltd (601607.SS)

Total Liabilities Summary of Shanghai Pharmaceuticals Holding Co., Ltd

Annual Total Liabilities Chart of Shanghai Pharmaceuticals Holding Co., Ltd (2023 - 1994)

Historical Annual Total Liabilities of Shanghai Pharmaceuticals Holding Co., Ltd (2023 - 1994)

Peer Total Liabilities Comparison of Shanghai Pharmaceuticals Holding Co., Ltd